Showing results (61-70 of 731) with videos related to
Sort By:
Pageof 74
Cancer Discovery|December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.Science Signaling|March 27, 2014
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signalingBerta Sanchez-Laorden, Amaya Viros, Maria Romina Girotti, et al.The Journal of Pathology|May 30, 2013
Parallel evolution of tumour subclones mimics diversity between tumoursPierre Martinez, Nicolai Juul Birkbak, Marco Gerlinger, et al.Cell Cycle (Georgetown, Tex.)|April 22, 2006
Chromosomal instability, colorectal cancer and taxane resistanceCharles Swanton, Ian Tomlinson, Julian DownwardAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Molecular profiling and the reclassification of cancer: divide and conquerJavier Munoz, Charles Swanton, Razelle KurzrockBiochemical Pharmacology|December 24, 2011
Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomicsAlvin J X Lee, Charles SwantonBritish Journal of Cancer|February 24, 2021
Understanding the impact of immune-mediated selection on lung cancer evolutionRachel Rosenthal, Charles Swanton, Nicholas McGranahanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Her2-targeted therapies in non-small cell lung cancerCharles Swanton, Andy Futreal, Tim EisenSeminars in Cancer Biology|February 25, 2021
Impact of cancer evolution on immune surveillance and checkpoint inhibitor responseYin Wu, Dhruva Biswas, Charles SwantonThe EMBO Journal|August 30, 2021
Cancer evolution: Darwin and beyondRoberto Vendramin, Kevin Litchfield, Charles SwantonPageof 74